NL8005330A - Reagens en werkwijze voor de bepaling van aldolase van het menselijke spiertype. - Google Patents
Reagens en werkwijze voor de bepaling van aldolase van het menselijke spiertype. Download PDFInfo
- Publication number
- NL8005330A NL8005330A NL8005330A NL8005330A NL8005330A NL 8005330 A NL8005330 A NL 8005330A NL 8005330 A NL8005330 A NL 8005330A NL 8005330 A NL8005330 A NL 8005330A NL 8005330 A NL8005330 A NL 8005330A
- Authority
- NL
- Netherlands
- Prior art keywords
- aldolase
- muscle type
- antibody
- enzyme
- rabbit
- Prior art date
Links
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 title claims description 50
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 title claims description 50
- 238000000034 method Methods 0.000 title claims description 45
- 210000003205 muscle Anatomy 0.000 title claims description 41
- 241000282414 Homo sapiens Species 0.000 title claims description 23
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 17
- 101710123627 Fructose-bisphosphate aldolase A Proteins 0.000 claims description 58
- 102100022277 Fructose-bisphosphate aldolase A Human genes 0.000 claims description 58
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 50
- 102000004190 Enzymes Human genes 0.000 claims description 42
- 108090000790 Enzymes Proteins 0.000 claims description 42
- 101000755879 Homo sapiens Fructose-bisphosphate aldolase A Proteins 0.000 claims description 36
- 239000007853 buffer solution Substances 0.000 claims description 21
- 239000003513 alkali Substances 0.000 claims description 19
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 16
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 16
- 210000002966 serum Anatomy 0.000 claims description 16
- 239000007790 solid phase Substances 0.000 claims description 12
- 238000002835 absorbance Methods 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 11
- 241000283690 Bos taurus Species 0.000 claims description 7
- 238000001042 affinity chromatography Methods 0.000 claims description 7
- 238000000354 decomposition reaction Methods 0.000 claims description 5
- 230000028327 secretion Effects 0.000 claims description 4
- 229940088598 enzyme Drugs 0.000 description 36
- 238000002474 experimental method Methods 0.000 description 33
- 239000000243 solution Substances 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 13
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 11
- 239000000427 antigen Substances 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 10
- 108091007433 antigens Proteins 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000003018 immunoassay Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 8
- 239000000523 sample Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- 229920002684 Sepharose Polymers 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- GNGACRATGGDKBX-UHFFFAOYSA-N dihydroxyacetone phosphate Chemical compound OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 108010044467 Isoenzymes Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 3
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000012089 stop solution Substances 0.000 description 3
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 102100027824 3'(2'),5'-bisphosphate nucleotidase 1 Human genes 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- WMDDNKROYKCDJC-UHFFFAOYSA-N [4-[3-oxo-1-(4-phosphonooxyphenyl)-2-benzofuran-1-yl]phenyl] dihydrogen phosphate Chemical compound C1=CC(OP(O)(=O)O)=CC=C1C1(C=2C=CC(OP(O)(O)=O)=CC=2)C2=CC=CC=C2C(=O)O1 WMDDNKROYKCDJC-UHFFFAOYSA-N 0.000 description 1
- KBMIMTREIPWGMW-UHFFFAOYSA-L [C+2]=O.C([O-])([O-])=O.[Na+] Chemical compound [C+2]=O.C([O-])([O-])=O.[Na+] KBMIMTREIPWGMW-UHFFFAOYSA-L 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- DHCLVCXQIBBOPH-UHFFFAOYSA-N beta-glycerol phosphate Natural products OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 1
- GHRQXJHBXKYCLZ-UHFFFAOYSA-L beta-glycerolphosphate Chemical compound [Na+].[Na+].CC(CO)OOP([O-])([O-])=O GHRQXJHBXKYCLZ-UHFFFAOYSA-L 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 description 1
- RNBGYGVWRKECFJ-UHFFFAOYSA-N fructose-1,6-phosphate Natural products OC1C(O)C(O)(COP(O)(O)=O)OC1COP(O)(O)=O RNBGYGVWRKECFJ-UHFFFAOYSA-N 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002518 glial effect Effects 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- ZKLLSNQJRLJIGT-UYFOZJQFSA-N keto-D-fructose 1-phosphate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)COP(O)(O)=O ZKLLSNQJRLJIGT-UYFOZJQFSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- CQTZJAKSNDFPOB-UHFFFAOYSA-L naphthalen-2-yl phosphate Chemical compound C1=CC=CC2=CC(OP([O-])(=O)[O-])=CC=C21 CQTZJAKSNDFPOB-UHFFFAOYSA-L 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12204779A JPS5648894A (en) | 1979-09-25 | 1979-09-25 | Reagent for measuring human muscular aldolase and its determination |
| JP12204779 | 1979-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8005330A true NL8005330A (nl) | 1981-03-27 |
Family
ID=14826285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8005330A NL8005330A (nl) | 1979-09-25 | 1980-09-24 | Reagens en werkwijze voor de bepaling van aldolase van het menselijke spiertype. |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS5648894A (enExample) |
| BE (1) | BE885376A (enExample) |
| CA (1) | CA1158549A (enExample) |
| CH (1) | CH648596A5 (enExample) |
| DE (1) | DE3036184A1 (enExample) |
| FR (1) | FR2466020A1 (enExample) |
| GB (1) | GB2062226B (enExample) |
| IT (1) | IT1141082B (enExample) |
| NL (1) | NL8005330A (enExample) |
| SE (1) | SE447422B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56125667A (en) * | 1980-03-07 | 1981-10-02 | Eisai Co Ltd | Reagent for measurement and measuring method for human muscle type aldolase |
| JPS57208459A (en) * | 1981-06-19 | 1982-12-21 | Eisai Co Ltd | Measuring method using enzyme-labelled antibody and reagent |
| DE3145936A1 (de) * | 1981-11-20 | 1983-06-01 | Behringwerke Ag, 3550 Marburg | "verfahren zur enzymimmunologischen bestimmung von lipase" |
| JP6754116B2 (ja) * | 2016-04-26 | 2020-09-09 | 学校法人近畿大学 | 大腸癌マーカー |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2128670B2 (de) * | 1971-06-09 | 1977-06-30 | Merck Patent Gmbh, 6100 Darmstadt | Immunologische isoenzym-bestimmungsmethode |
| JPS54147097A (en) * | 1978-05-11 | 1979-11-16 | Eisai Co Ltd | Reagent for detecting muscleetype aldolase |
-
1979
- 1979-09-25 JP JP12204779A patent/JPS5648894A/ja active Pending
-
1980
- 1980-09-23 CH CH7209/80A patent/CH648596A5/de not_active IP Right Cessation
- 1980-09-24 GB GB8030730A patent/GB2062226B/en not_active Expired
- 1980-09-24 CA CA000360973A patent/CA1158549A/en not_active Expired
- 1980-09-24 BE BE0/202218A patent/BE885376A/fr not_active IP Right Cessation
- 1980-09-24 IT IT24877/80A patent/IT1141082B/it active
- 1980-09-24 SE SE8006667A patent/SE447422B/sv not_active IP Right Cessation
- 1980-09-24 NL NL8005330A patent/NL8005330A/nl not_active Application Discontinuation
- 1980-09-24 FR FR8020472A patent/FR2466020A1/fr active Granted
- 1980-09-25 DE DE19803036184 patent/DE3036184A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| IT8024877A0 (it) | 1980-09-24 |
| JPS5648894A (en) | 1981-05-02 |
| DE3036184A1 (de) | 1981-04-16 |
| CH648596A5 (de) | 1985-03-29 |
| SE8006667L (sv) | 1981-03-26 |
| FR2466020B1 (enExample) | 1983-07-08 |
| IT1141082B (it) | 1986-10-01 |
| SE447422B (sv) | 1986-11-10 |
| CA1158549A (en) | 1983-12-13 |
| BE885376A (fr) | 1981-03-24 |
| GB2062226B (en) | 1983-11-30 |
| FR2466020A1 (fr) | 1981-03-27 |
| GB2062226A (en) | 1981-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS200196B2 (en) | Method of creatincynasis-mb efficieny determination | |
| US4804625A (en) | Assay procedures | |
| US4366242A (en) | Method and agent for the immunological determination of enzymes | |
| JPH01118769A (ja) | 抗原特異的な抗体の一段階測定法およびそれに適する試薬 | |
| Baykov et al. | Inorganic pyrophosphatase as a label in heterogeneous enzyme immunoassay | |
| US4729961A (en) | Process for the detection and assay by erythroadsorption | |
| JPH10511776A (ja) | レセプター：遊離リガンド（リランド）複合体ならびにそれに基づくアッセイおよびキット | |
| Lindstedt et al. | Analytical and clinical evaluation of a radioimmunoassay for gastrin. | |
| NL8005330A (nl) | Reagens en werkwijze voor de bepaling van aldolase van het menselijke spiertype. | |
| Karapitta et al. | A new homogeneous enzyme immunoassay for thyroxine using glycogen phosphorylase b–thyroxine conjugates | |
| AU4465001A (en) | Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor | |
| EP0123265A1 (en) | Zymogen activation, cascade amplification immunoassay | |
| US4237044A (en) | Antibodies against creatinekinase-M8 and process for the production thereof | |
| JPH0677019B2 (ja) | 酵素標識抗体の安定化法 | |
| EP0166583B1 (en) | Compositions for enzyme immunoassay of prostaglandins | |
| US5231031A (en) | Method for assessing risk of diabetes-associated pathologic conditions and efficacy of therapies for such conditions | |
| JPH0326787B2 (enExample) | ||
| JP3171681B2 (ja) | 糖化蛋白の測定方法 | |
| US5460975A (en) | Diphenylmethane derivatives, process for their production and their use for the displacement of iodothyronines from proteins which bind them | |
| NL8101068A (nl) | Reagens en werkwijze voor de bepaling van aldolase van het menselijke spiertype. | |
| JP2000180446A (ja) | 干渉作用を回避する方法及び試薬 | |
| JPS607362A (ja) | 酵素を用いた抗原決定基具有物質の測定法 | |
| JPH08101196A (ja) | Ｃ−反応性蛋白質測定用試薬 | |
| JPS6217707B2 (enExample) | ||
| JP3319073B2 (ja) | 免疫学的測定方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BV | The patent application has lapsed |